Issue 4 2024
-
Opening Plenary Session showcases cutting-edge technological advances opening new frontiers in cancer science
Aviv Regev, PhD, FAACR; Jakob Nikolas Kather, MD, MSc; Benjamin F. Cravatt, PhD; and Carolyn R. Bertozzi, PhD, FAACR, described evolving and emerging technological advances—from cell atlases and artificial intelligence-based biomarkers to proteomics and bioorthogonal chemistry—that are driving new discoveries and new directions in cancer research.
-
Plenary speakers discuss growing understanding of early cancer and precancer biology
Margaret A. Goodell, PhD, FAACR, presented how clonal hematopoiesis can drive tumor risk and resistance during a Saturday plenary session on discovery science in early cancer biology and interception.
-
Highlights for Monday, April 8: NCI Director Address, Profiling Tumor Ecosystems Plenary Session, and more
Annual Meeting Program Chairs Keith T. Flaherty, MD, FAACR, and Christina Curtis, PhD, MSc, preview notable items on Monday’s schedule to help you plan your day.
-
Major symposium will focus on shared risk factors for cancer, cardiovascular disease, and metabolic disease
Michael N. Pollak, MD, will chair a Monday symposium on novel and exciting data-driven insights on obesity, nicotine addiction, and suboptimal dietary patterns.
-
Special session will explore mechanistic insights into cancer emerging from tumors with simple genomes
Charles W. M. Roberts, MD, PhD, will chair a Monday evening panel discussion on lessons learned from studies of simple genome cancers.
-
Four forums scheduled for Monday evening
Monday forums will cover topics including financial hardship in cancer care; treatment and research capabilities in low-resource settings; new weight-loss drugs and the obesity-cancer axis; and optimizing cancer vaccines.
